Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms

Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms


A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022.

Vanessa Leroy | Bloomberg | Getty Images

Covid-19 vaccination is linked to a slight increase in the length of a women’s menstrual cycle, delaying the beginning of bleeding by a few hours, according to a large international study funded by the National Institutes of Health.

Dr. Diana Bianchi, head of NIH’s child health and human development institute, said the changes following vaccination appear small, temporary and within the normal range. However, the longer menstrual cycle, typically about a month long, didn’t necessarily increase the number of days of bleeding, according to health agency.

A change in menstrual cycle length of eight days or less is considered within the normal range of variation, NIH said. Participants’ menstrual cycles increased by an average of .71 days, or less than 24 hours, after the first vaccine dose and by just over half a day after the second dose, according to the study’s findings. Women who received both vaccine doses in a single menstrual period saw their cycle increase by 3.91 days.

But more than 1,300 women saw their cycle increase by eight days or more, representing 6.2% of vaccinated individuals and 5% of unvaccinated people in the study. Younger women who had a longer cycle before vaccination were more likely to see a bigger delay in the start of their periods.

After the vaccination series was complete, cycle length had largely returned to normal for women who received one dose per menstrual cycle and by about 20 hours for those who received both doses in a single cycle.

Nearly 20,000 people participated in the study across Canada, the U.K., the U.S., Europe and other parts of the world. Participants received one of nine different vaccines: Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Covishield, Sputnik, Covaxin, Sinopharm and Sinovac.

The changes in menstrual cycle length did not differ between vaccines.

The researchers used data from a fertility tracking app called Natural Cycles. Women provided information on their temperature and menstrual cycle length to the app. Users of the app can select an option to provide their data for research purposes without any personally identifying information.

The researchers had released preliminary findings in January suggesting an association between Covid vaccination and increased menstrual cycle length, and the study published this week confirmed the link. NIH provided $1.67 million to five research institutions to investigate the issue.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know
Health

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food and Drug Administration may add its strongest safety warning to Covid shots – marking another major shift in vaccine oversight.  It could also expand a […]

Read More
‘The next protein’: Fiber is shaping up to be the latest grocery obsession
Health

‘The next protein’: Fiber is shaping up to be the latest grocery obsession

Workers are suspended on a Pepsi sign on a building outside of Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, U.S., February 9, 2024. Brian Snyder | Reuters One of this year’s top food trends is facing some tough competition. Protein captivated consumers and food companies in 2025, but fiber is increasingly stealing the […]

Read More
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More